Subtypes of tumor-associated neutrophils and their roles in cancer immunotherapy
- 5 May 2025
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 212, 104763
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operationCell Biology and Toxicology, 2024
- Interferon-stimulated neutrophils as a predictor of immunotherapy responseCancer Cell, 2024
- Advances and prospects of mRNA vaccines in cancer immunotherapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024
- High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancerCancer Cell, 2022
- Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapyCancer Cell, 2022
- Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung CancerCancer Cell, 2016
- Rhythmic Modulation of the Hematopoietic Niche through Neutrophil ClearanceCell, 2013
- Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differencesCellular and Molecular Life Sciences, 2013
- Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncologyCancer Immunology, Immunotherapy, 2012
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TANCancer Cell, 2009